Skip to main content
OpenTrials

Clinical trial condition

Crystal Arthropathies

Explore clinical trials studying Crystal Arthropathies. Study availability and eligibility vary by location and protocol.

315 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Crystal Arthropathies trial results

Completed

Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout

NCT01129648

Conditions
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +12 more
Locations
  • Scottsdale, Arizona, United States
  • Irvine, California, United States
  • South Miami, Florida, United States
  • Honolulu, Hawaii, United States
View all 18 locations
View Trial Details
Completed

Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout

NCT00985127

Conditions
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +12 more
Locations
  • Radiant Research, Inc. Scottsdale, Arizona, United States
  • Catalina Pointe Clinical Research Tucson, Arizona, United States
  • Irvine Center for Clinical Research Irvine, California, United States
  • San Diego Arthritis Medical Clinic San Diego, California, United States
View all 24 locations
View Trial Details
Completed

Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout

NCT01356498

Conditions
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +9 more
Locations
  • Kaiser Permanente Medical Center, Clinical Trials Unit San Francisco, California, United States
  • Pacific Arthritis Center Medical Group Santa Maria, California, United States
  • Agilence Arthritis & Osteoporosis Medical Center Whittier, California, United States
  • Veterans Affairs Medical Center Washington D.C., District of Columbia, United States
View all 22 locations
View Trial Details
Completed

Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients

NCT00675103

Conditions
Arthritis, Arthritis, Gouty, Chronic Gout Refractory to Conventional Therapy, +11 more
Locations
  • University of Chicago- Dept. Biological Services Chicago, Illinois, United States
  • The Center for Rheumatology and Bone Research Wheaton, Maryland, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Portland Rheumatology Clinic, L.L.C. Lake Oswego, Oregon, United States
View Trial Details
Completed

Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout

NCT00325195

Conditions
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +9 more
Locations
  • UAB Arthritis Clinical Intervention Program Birmingham, Alabama, United States
  • University of Arizona Arthritis Center Tucson, Arizona, United States
  • NEA Clinic Jonesboro, Arkansas, United States
  • UCSD Rheumatology Division La Jolla, California, United States
View all 56 locations
View Trial Details

Related conditions